Drugs that target various components of the systemic RAS, including angiotensin ii type 1 receptor blockers (ARBs), renin inhibitors, and angiotensin converting enzyme inhibitors, are used to treat heart failure [68]. The gene discussed is REN; the disease is heart failure.